HomeCompareRELOF vs MRK

RELOF vs MRK: Dividend Comparison 2026

RELOF yields 2.06% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RELOF wins by $23.5K in total portfolio value· pulled ahead in Year 7
10 years
RELOF
RELOF
● Live price
2.06%
Share price
$11.84
Annual div
$0.24
5Y div CAGR
45.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$80.3K
Annual income
$24,357.65
Full RELOF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — RELOF vs MRK

📍 RELOF pulled ahead of the other in Year 7

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRELOFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RELOF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RELOF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RELOF
Annual income on $10K today (after 15% tax)
$174.83/yr
After 10yr DRIP, annual income (after tax)
$20,704.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, RELOF beats the other by $12,375.59/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RELOF + MRK for your $10,000?

RELOF: 50%MRK: 50%
100% MRK50/50100% RELOF
Portfolio after 10yr
$68.5K
Annual income
$17,077.90/yr
Blended yield
24.92%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

RELOF
No analyst data
Altman Z
2.4
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RELOF buys
0
MRK buys
0
No recent congressional trades found for RELOF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRELOFMRK
Forward yield2.06%2.76%
Annual dividend / share$0.24$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR45.2%32.7%
Portfolio after 10y$80.3K$56.8K
Annual income after 10y$24,357.65$9,798.13
Total dividends collected$54.8K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: RELOF vs MRK ($10,000, DRIP)

YearRELOF PortfolioRELOF Income/yrMRK PortfolioMRK Income/yrGap
1$10,999$298.65$11,206$366.19$207.00MRK
2$12,214$445.75$12,650$502.35$436.00MRK
3$13,741$671.74$14,407$694.19$666.00MRK
4$15,728$1,025.50$16,585$967.82$857.00MRK
5$18,422$1,592.88$19,342$1,363.89$920.00MRK
6$22,244$2,531.78$22,913$1,947.19$669.00MRK
7← crossover$27,949$4,148.30$27,662$2,823.89+$287.00RELOF
8$36,979$7,073.16$34,159$4,173.35+$2.8KRELOF
9$52,266$12,699.31$43,337$6,308.80+$8.9KRELOF
10$80,283$24,357.65$56,776$9,798.13+$23.5KRELOF

RELOF vs MRK: Complete Analysis 2026

RELOFStock

Relo Group, Inc. provides corporate fringe benefit services in Japan. The company offers leased corporate housing management services; and residential property management services. It also provides life support services, such as leisure and accommodation services, as well as upskilling, medical examination, childcare, and nursing services. In addition, the company offers global relocation support services, including services related to working visa applications, medical examinations, vaccinations, and moving house overseas; and other services, such as the creation of overseas transfer regulations, arranging tickets for business trips, and house management during a transfer. Further, it engages in the operation of resorts, as well as in the insurance business. The company was formerly known as Relo Holdings, Inc. and changed its name to Relo Group, Inc. in July 2016. Relo Group, Inc. was incorporated in 1967 and is headquartered in Tokyo, Japan.

Full RELOF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this RELOF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RELOF vs SCHDRELOF vs JEPIRELOF vs ORELOF vs KORELOF vs MAINRELOF vs JNJRELOF vs ABBVRELOF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.